Natriuretic peptides as markers of cardiovascular risk: the story continues
- PMID: 22134932
- PMCID: PMC3228612
- DOI: 10.4065/mcp.2011.0725
Natriuretic peptides as markers of cardiovascular risk: the story continues
Comment on
-
B-type natriuretic peptide as a biomarker beyond heart failure: speculations and opportunities.Mayo Clin Proc. 2005 Aug;80(8):1029-36. doi: 10.4065/80.8.1029. Mayo Clin Proc. 2005. PMID: 16092582 Review.
-
Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: a 9-year follow-up study.Mayo Clin Proc. 2011 Dec;86(12):1154-60. doi: 10.4065/mcp.2011.0437. Mayo Clin Proc. 2011. PMID: 22134933 Free PMC article.
References
-
- Jacques J. Hippocrates: Medicine and Culture. DeBevoise MB, Trans. Baltimore, MD: Johns Hopkins University Press, 1999
-
- McGrath MF, de Bold ML, de Bold AJ. The endocrine function of the heart. Trends Endocrinol Metab. 2005;16:469–477 - PubMed
-
- Lafontan M, Moro C, Sengenes C, Galitzky J, Crampes F, Berlan M. An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans. Arterioscler Thromb Vasc Biol. 2005;25:2032–2042 - PubMed
-
- McKie PM, Burnett JC., Jr B-type natriuretic peptide as a biomarker beyond heart failure: speculations and opportunities. Mayo Clin Proc. 2005;80(8):1029–1036 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
